Sign in: Staff/Students
A major clinical trial involving patients with obesity and type 2 diabetes, led by researchers from across the University of Liverpool has been funded £1 million.
The group, made up of researchers from University Hospital Aintree, MARIARC, the Department of Psychological Sciences, Institute of Ageing and the Liverpool Clinical Trials Unit (LCTU), has been awarded the funds to examine different aspects of obesity in people with diabetes in new experimental ways.
The study will run a randomized controlled trial of a novel treatment combination that may help patients control their blood sugar and weight, to examine changes in people’s energy balance, appetite, body composition, glucose, fat and metabolism.
The cardiovascular function of obese patients with type 2 diabetes will also be examined. It will examine important clinical end points as well as provide mechanistic insight.
The funding has been provided as an investigator-initiated research grant by AstraZeneca, a major contributor to UK science and innovation investment, economic prosperity and to patient health.
Involved in the group are Dr Daniel Cuthbertson, Professor John Wilding, Professor Graham Kemp, Professor Jason Halford, Dr Jo Harrold, Victoria Sprung and Dr Emily Brown.
Dr Dan Cuthbertson, the study principal investigator, said: “This study will allow us to expand our current diabetes/obesity clinical trial portfolio and builds upon previous clinical trial collaborations between Psychology, MARIARC and Aintree clinical academics.
“Our work has the potential to profound influence clinical practice of obesity and type 2 diabetes management.”
For more information about the study please contact email@example.com
You must be logged in to post a comment.
All recent news
Reminder: Being mindful of our neighbours
GALLERY: Digital Innovation Facility opening
Students’ bold designs that would transform Liverpool’s city centre
New website to help families and professionals navigate the complexities of missing persons
£1.25M to design revolutionary upper body mobility suit for progressive neuromuscular diseases
Becoming an Expert: Wei Huang is a 4th year PhD student with the Trustworthy Autonomous Cyber-Physical Systems Laboratory located in the Digital Innovation Facility➡️http://bit.ly/3MOJS0z
Congratulations to Professor Tom Solomon on his appointment as the new Director of The Pandemic Institute! Read more about this story and the exciting new funding call focusing on the unprecedented spread of monkey pox outside of African countries here: https://tinyurl.com/PandemicInstituteDirector
Dr @farnaznickpour & @inclusionaries_ lab are part of an innovative project with @DuchenneUK & @SMA_UK awarded £1.25M from @PostcodeLottery to design a revolutionary upper body mobility suit for progressive neuromuscular diseases.
Find out more: http://bit.ly/3LKjtQb